Innsbruck, Austria

Christoph Langes

USPTO Granted Patents = 11 

 

 

Average Co-Inventor Count = 3.7

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Kundl, AT (2016)
  • Innsbruck, AT (2012 - 2021)

Company Filing History:


Years Active: 2012-2021

Loading Chart...
Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: Christoph Langes: Innovator in Pharmaceutical Chemistry

Introduction

Christoph Langes is a prominent inventor located in Innsbruck, Austria, known for his substantial contributions to pharmaceutical chemistry. With a total of 11 patents to his name, Langes has made significant strides in the development of therapeutic compounds aimed at treating hyperkinetic movement disorders.

Latest Patents

Among his most recent inventions are two notable patents concerning valbenazine, a medication used primarily in the treatment of tardive dyskinesia. The first invention, titled "Crystalline Forms of Valbenazine Salts," focuses on a crystalline hydrate and anhydrous form of valbenazine ditosylate, along with methods of preparation. The second patent, "Crystalline Valbenazine Free Base," discloses crystalline valbenazine itself and its pharmaceutical applications, including methods for using it in treating hyperkinetic disorders.

Career Highlights

Throughout his career, Christoph Langes has greatly advanced pharmaceutical science, working with respected companies such as Sandoz AG and Hexal AG. His innovative solutions in drug formulation have played a crucial role in improving treatment options for patients with movement disorders, showcasing his commitment to enhancing healthcare.

Collaborations

Langes has worked alongside distinguished professionals in the field, including his coworkers Ulrich Griesser and Andreas Hotter. Their collaborative efforts reflect a shared vision for innovation in pharmacology, further enriching Langes' contributions to the industry.

Conclusion

With a rich portfolio of patents and collaborative projects, Christoph Langes continues to be a key figure in pharmaceutical innovation. His work significantly impacts the treatment landscape for hyperkinetic movement disorders, emphasizing the importance of research and development in advancing human health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…